Dow Jones Top Company Headlines at 7 AM ET: Elon Musk's SpaceX, Tesla Fall Premarket After Democrats Sweep Midterms | CVS ...
Elon Musk's SpaceX, Tesla Fall Premarket After Democrats Sweep Midterms
Shares fell sharply premarket after Democratic candidates swept the midterm elections, handing a defeat to Republicans backed by Musk to the tune of hundreds of millions of dollars.
----
CVS Raises Forecast on Health Care Benefits, Pharmacy Gains
CVS Health raised its full-year guidance on gains in its health-care benefits and pharmacy segments, but said it remains cautious amid high costs and potential macroeconomic headwinds.
----
Lockheed Martin to Pay $29.5 Million to Settle Federal Probe Over Diversity Efforts
The Trump administration has been investigating big U.S. companies under a novel use of a law meant to police U.S. government contractors.
----
CVS Will Break Off Its Namesake Pharmacies
The company will split its retail pharmacies from its insurance and pharmacy-benefit operations.
----
Pandora Shares Jump as Sales Continue to Rise
The jeweler reported an acceleration in sales growth despite a challenging consumer environment as it heads into the crucial festive shopping season, sending its shares higher.
----
BMW Cuts Outlook Again as Carmaker Revs Up on Restructuring
BMW warned that its core automotive segment could slide to a loss for a closely watched profitability metric, as the group moves to speed up its restructuring program.
----
Pfizer CEO Bourla Bets the Viagra Playbook Can Crack the Obesity Market
Pfizer CEO Albert Bourla says the company can replicate its past success as it leads a renewed push into the weight-loss drug market.
----
Novo Nordisk Lifts Guidance as Rollout of Wegovy Weight-Loss Pill Continues
The Danish drugmaker raised its guidance for the year after noting an improved outlook for its key obesity and diabetes drugs, particularly in markets outside of the U.S.
----
3M Announces $7.4 Billion Settlement in 'Forever Chemicals' Injuries Case
The agreement covers up to 120,000 plaintiffs who claim they were hurt by chemicals containing PFAS.
----
Silicon Valley Promises AI Will Cure Disease. Drugmaker CEOs Aren't Buying It.
No drug designed by artificial intelligence has won FDA clearance, and pharma leaders say biology is the obstacle.
----
AMD Beats Wall Street Expectations as it Pivots to Data-Center First Status
The chip maker's shares soared.
----
Booking Profit, Sales Fall as Global Conflicts Wear on Travel Demand
The online travel agency posted a third-quarter profit of $2.72 billion, or $3.61 a share, as revenue fell 1% to $8.89 billion.
----
Block Inc. Profit Rises as Square Payment Volume Jumps
The owner of Cash App and Square reported third-quarter net income of $565.6 million, up from $461.5 million the year prior.
----
Super Micro Computer Revenue Surges on AI Infrastructure Demand
The server company's first-quarter revenue rose to $19.95 billion, up from $5.02 billion a year prior, as customers continued spending heavily on artificial-intelligence infrastructure.
----
The Battle for the Biggest Weed Merger Ends in Canada
Organigram Global agreed to buy Aurora Cannabis, topping a hostile bid from U.S. weed chain Curaleaf Holdings.
----
Google Curbs AI in School Accounts After Pushback
The search company turns off Gemini chatbot and Google Search by default for schoolchildren after a WSJ investigation into Google's AI rollout in schools.
(END) Dow Jones Newswires
November 04, 2026 07:15 ET (12:15 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
3 Stocks to Sell and 3 Stocks to Buy for November
This Once-Hot AI Stock Now Looks Deeply Undervalued
The 10 Best Companies to Invest in Now
3 of the Best Dividend Stocks to Own
United States